Carcinoid syndrome

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Crinetics Pharmaceuticals Inc. Commercial
    PALTUSOTINE
    2024-519875-24-00 8 countries 2025 n=97
    Recruiting

Phase II

1 trial
  • Crinetics Pharmaceuticals Inc. Commercial
    PALTUSOTINE
    2024-511922-30-00 1 country 2023 n=2
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Crinetics Pharmaceuticals Inc. Commercial 2 Phase II, Phase III 1
New trials by year
2023
1
2025
1
← All indication landscapes